Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs alfentanil anesthesia for ERCP in elderly patients
ChiCTR2000034707Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and alfentanil in None (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Basic vital signs at each observation time point, Analgesic effect and 1 more. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
nalbuphinealfentanil
Beyond the preview
Go deeper on ChiCTR2000034707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034707.